𝔖 Bobbio Scriptorium
✦   LIBER   ✦

155 PTK787/ZK 222584 (PTK/ZK), a potent orally active and highly selective inhibitor of VEGFR kinases, is highly efficacious in various experimental tumor models either as mono- or combination therapy

✍ Scribed by H. Hess-Stumpp; M. Haberey; A. Reichel; K.H. Thierauch


Book ID
118621338
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
145 KB
Volume
2
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.